Navigation Links
New White Paper Helps OEM Design Engineers Navigate the Force Transducer Selection Process
Date:6/16/2009

Design engineers have always faced unique challenges in specifying force sensors, or force transducers. With an abundance of available force sensors on the market, from load cells to strain gauges to thin and flexible resistive technology, selecting the right sensor for a particular application can be overwhelming. "Force Sensors for Design," a newly-published white paper from force sensor experts Tekscan, Inc. illustrates how to find a force transducer with the right combination of performance, cost, turnaround-time, engineering support from the manufacturer, and more.

Boston, MA (PRWEB) June 16, 2009 -- OEM design engineers have always faced unique challenges in specifying force sensors, or force transducers. "Force Sensors for Design," a newly-published white paper from Machine Design magazine and force sensor experts Tekscan, Inc. illustrates that, in addition to finding a force transducer with the right performance specifications, challenges include issues such as cost, turnaround-time, engineering support from the manufacturer, customization capabilities, off-the-shelf options for prototyping and/or lower quantities, and more. With an abundance of available force sensors on the market, from load cells to strain gauges to thin and flexible resistive technology, selecting the right sensor for a particular application can be overwhelming. In addition, with more and more engineers working across disciplines in their positions, many product designers find themselves in unfamiliar territory at times. Proper guidance is essential.

Tekscan, Inc. demonstrates a commitment
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Tobacco Control Bill Heads to White House as Health Groups Cheer
2. Cornflakes, White Bread Could Boost Heart Risk
3. White Paper Explains Package Validation Requirements For Medical Devices & Combinatory Products
4. RiskMetrics Recommends That Providence Service Corporation Stockholders Vote for Providences Director Nominees on the White Proxy Card
5. PROXY Governance and Glass Lewis Recommend That Stockholders Vote the White Proxy Card in Support of All Providence Nominees
6. AMA Outlines Initiatives to White House to Help Slow Increases In Health Spending
7. Avantpage Translations Releases White Paper on Capturing The Fastest Growing Healthcare Market In America
8. Monterey Mushrooms Launches Vitamin D Enriched Sun Grill-A-Bella and White Mushrooms
9. Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making
10. Hummingbird Coaching's New White Paper on Health Coaching: Build it or Buy it?
11. Carefxs Newest White Paper Illuminates Healthcare CIOs Growing Role in Operations, Strategic Thinking and IT Project Decision Making
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New White Paper Helps OEM Design Engineers Navigate the Force Transducer Selection Process
New White Paper Helps OEM Design Engineers Navigate the Force Transducer Selection Process
Other Medicine News:Health News:Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford 2Health News:American Kidney Fund Issues Appeal for Disaster Relief Contributions 2Health News:American Kidney Fund Issues Appeal for Disaster Relief Contributions 3Health News:SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients 2Health News:SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients 3Health News:HTH Worldwide to Provide Mobile Healthcare Tool to HRG North America's Affiliate Program 2Health News:HTH Worldwide to Provide Mobile Healthcare Tool to HRG North America's Affiliate Program 3Health News:Merck's odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study 2Health News:Merck's odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study 3Health News:Estrogen Cream No Match for Sun-Damaged Skin 2
Breaking Medicine Technology:Indiana Blood Center Taps tw telecom for Data, Internet and IP Telephony Services 2National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 1Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 1National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 2National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 4National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 1Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 2Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 3Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 4Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 6Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 7Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 8Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 9Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 10
Other Medicine Technology:Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 2Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 3Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 4